Cargando…

Lysophosphatidic Acid Induces Neointima Formation Through PPARγ Activation

Neointimal lesions are characterized by accumulation of cells within the arterial wall and are a prelude to atherosclerotic disease. Here we report that a brief exposure to either alkyl ether analogs of the growth factor–like phospholipid lysophosphatidic acid (LPA), products generated during the ox...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chunxiang, Baker, Daniel L., Yasuda, Satoshi, Makarova, Natalia, Balazs, Louisa, Johnson, Leonard R., Marathe, Gopal K., McIntyre, Thomas M., Xu, Yong, Prestwich, Glenn D., Byun, Hoe-Sup, Bittman, Robert, Tigyi, Gabor
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2004
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212723/ https://www.ncbi.nlm.nih.gov/pubmed/15007093 http://dx.doi.org/10.1084/jem.20031619

Ejemplares similares

Aiming drug discovery at lysophosphatidic acid targets
por: Tigyi, Gabor
Publicado: (2010)

Regulation of Tumor Immunity by Lysophosphatidic Acid
por: Lee, Sue Chin, et al.
Publicado: (2020)

NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ
por: Luan, Peipei, et al.
Publicado: (2019)

Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions
por: Li, Chunying, et al.
Publicado: (2005)

Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
por: Tigyi, Gábor, et al.
Publicado: (2021)

Lysophosphatidic acid induces proliferation and osteogenic differentiation of human dental pulp stem cell through lysophosphatidic acid receptor 3/extracellular signal-regulated kinase signaling axis
por: Heo, Soon Chul, et al.
Publicado: (2023)

A Metabolically-Stabilized Phosphonate Analog of Lysophosphatidic Acid Attenuates Collagen-Induced Arthritis
por: Nikitopoulou, Ioanna, et al.
Publicado: (2013)

Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis
por: Lin, Kuan-Hung, et al.
Publicado: (2016)

PAF is a potent pyrogen and cryogen in rodents, but it does not mediate thermoregulatory responses to bacterial endotoxin
por: Marathe, Gopal K, et al.
Publicado: (2015)

Dual Action of Lysophosphatidate-Functionalised Titanium: Interactions with Human (MG63) Osteoblasts and Methicillin Resistant Staphylococcus aureus
por: Skindersoe, Mette Elena, et al.
Publicado: (2015)

Correction: Dual Action of Lysophosphatidate-Functionalised Titanium: Interactions with Human (MG63) Osteoblasts and Methicillin Resistant Staphylococcus aureus
por: Skindersoe, Mette Elena, et al.
Publicado: (2016)

Preserved glucose tolerance in high-fat-fed C57BL/6 mice transplanted with PPARγ(−/−), PPARδ(−/−), PPARγδ(−/−), or LXRαβ(−/−) bone marrow
por: Marathe, Chaitra, et al.
Publicado: (2009)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

MCMV induces neointima in IFN-γR-/- mice: Intimal cell apoptosis and persistent proliferation of myofibroblasts
por: Hamamdzic, Damir, et al.
Publicado: (2001)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)

Uremia does not affect neointima formation in mice
por: Aarup, Annemarie, et al.
Publicado: (2017)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Human hepatocyte growth factor inhibits early neointima formation in rabbit abdominal aortae following ultrasound-guided balloon injury
por: Mei, Li, et al.
Publicado: (2017)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet
por: Horikawa, Tsuyoshi, et al.
Publicado: (2020)

Neointima development in externally stented saphenous vein grafts
por: Węglarz, Przemysław, et al.
Publicado: (2016)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Nuclear receptor corepressors and PPARγ
por: Cohen, Ronald N.
Publicado: (2006)

PPARγ in Kidney Physiology and Pathophysiology
por: Kiss-Tóth, Éva, et al.
Publicado: (2008)

PPARγ tackles treacherous T cells
por: Leslie, Mitch
Publicado: (2009)

Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012)

Gastrointestinal Cytoprotection by PPARγ Ligands
por: Naito, Yuji, et al.
Publicado: (2010)

PPARγ in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2012)

Prostaglandins as PPARγ Modulators in Adipogenesis
por: Fujimori, Ko
Publicado: (2012)

The Role of PPAR-γ in Allergic Disease
por: Stark, Julian M., et al.
Publicado: (2021)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_nirigkm1cbs5liskap0uq4ads0